Korean J Hematol.  2011 Dec;46(4):211-213. 10.5045/kjh.2011.46.4.211.

Lymphoma stem cells: A step toward a new therapeutic target

• Kim SJ

• KMID: 2251979
• DOI: http://doi.org/10.5045/kjh.2011.46.4.211

Abstract

No abstract available.

MeSH Terms

Lymphoma

Figure

• 

  Fig. 1 Primary cells from malignant ascites of a refractory B-cell non-Hodgkin lymphoma patient are sorted as a side population (P3) and a non-side population (P4) using flow cytometry (A). The side population (P3) in the tail region of the dot plot is reduced when the cells are incubated with verapamil (B).

Reference

1. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414:105–111. PMID: 11689955.

2. Warner JK, Wang JC, Hope KJ, Jin L, Dick JE. Concepts of human leukemic development. Oncogene. 2004; 23:7164–7177. PMID: 15378077.

3. Martinez-Climent JA, Fontan L, Gascoyne RD, Siebert R, Prosper F. Lymphoma stem cells: enough evidence to support their existence? Haematologica. 2010; 95:293–302. PMID: 20139392.

4. Jones RJ, Gocke CD, Kasamon YL, et al. Circulating clonotypic B cells in classic Hodgkin lymphoma. Blood. 2009; 113:5920–5926. PMID: 19188663.

5. Willis TG, Dyer MJ. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood. 2000; 96:808–822. PMID: 10910891.

6. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996; 183:1797–1806. PMID: 8666936.

7. Nakashima M, Ishii Y, Watanabe M, et al. The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma. Cancer Sci. 2010; 101:2490–2496. PMID: 20735433.

8. Shafer JA, Cruz CR, Leen AM, et al. Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma. Leuk Lymphoma. 2010; 51:870–880. PMID: 20367572.

9. Vega F, Davuluri Y, Cho-Vega JH, et al. Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and dissemination. J Cell Mol Med. 2010; 14:1532–1545. PMID: 19656242.

10. Jung HJ, Chen Z, McCarty N. Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma. Leuk Lymphoma. 2011; 52:1066–1079. PMID: 21599592.